Alvotech (ALVO)
Alvotech (ALVO) is a healthcare company (drug manufacturers - specialty & generic) based in Luxembourg. The share price is $4.33, down 1.70% on the day, which values the company at $1.55B. Price as of 17 Nov 2026, 17:29 UTC, from Yahoo Finance.
Key facts
- Share price
- $4.33−1.70% today
- Market value
- $1.55B
- Forward P/E
- 20.4×
- Funk Score
- 48/100
- 200-week average
- $9.2453% below
- Sector
- Healthcare
Figures as of . Prices from Yahoo Finance (may be delayed); statements from company filings with the SEC and Yahoo Finance. Estimates, not advice.
Alvotech in more detail
ALVO trades at 20.4× next year's expected earnings, 3.1× sales. It sits 53% below its 200-week average of $9.24.
Its Funk Score is 48 out of 100 (financial strength 0.6, profitability 3.7, growth 10.0, each out of 10).
Worth checking: Altman Z in the distress zone; Weak Piotroski score.
2 of the superinvestors tracked here hold ALVO, including Andrew Spokes (0.1% of the portfolio), Howard Marks (0.0% of the portfolio).
Superinvestors holding ALVO
2 of the investors tracked here report a position in their latest 13F filing.
- Andrew Spokes Farallon Capital Management0.09% of portfolio · $16.6M · Q3 2026
- Howard Marks Oaktree Capital Management0.01% of portfolio · $361.6K · trimmed · Q2 2026
Alvotech (ALVO): questions and answers
What is Alvotech's market cap?
Alvotech is valued at $1.55B at a share price of $4.33.
Is ALVO above its 200-week moving average?
No. ALVO is 53.1% below its 200-week average of $9.24. Long-term investors watch that line because strong companies rarely trade below it for long.
How fast is Alvotech growing?
Over the last three fiscal years Alvotech's revenue grew 91.9% a year.
Does ALVO pay a dividend?
Alvotech does not currently pay a regular dividend.
Which famous investors own ALVO?
In their latest quarterly filings, Andrew Spokes (0.1% of the portfolio), Howard Marks (0.0% of the portfolio) hold ALVO. These filings are published up to 45 days after each quarter ends, so positions may have changed since.
Learn to read these numbers
All stocks guides →- Altman Z-score: formula, zones and where it fails
The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.
- Analyst price targets and ratings: what they mean
An analyst price target is a research analyst's estimate of where a share price will be at a set horizon, such as twelve months; a rating such as buy or hold is that analyst's recommendation. A consensus is an average or median of the targets a data provider has collected. Studies have found targets on average well above later prices.
- Free cash flow and FCF yield explained
Free cash flow is the cash a business generates from operations minus what it spends on equipment, buildings and other long-lived assets. Free-cash-flow yield divides that cash by the company's market value: $5 billion of free cash flow on a $100 billion company is a 5% yield. It is cash available to owners and lenders, not profit.
Cite this page
Funkfolio, “Alvotech (ALVO) stock: price, valuation and fundamentals”, data as of 17 November 2026. https://funkfolio.com/stock/ALVO
Underlying data: Yahoo Finance; company filings with the SEC.